New HCA platform for oncology

Published by Nathalie MAUBON on

As oncology is the first used in HCS, Perkin Elmer has developped new High Content Analysis Platform dedicted for Cancer Applications as you can see below:

source: http://www.businesswire.com/news/home/20140407005786/en/Content-Screening-Platform-Advances-High-Content-Analysis-Cancer#.U1OZnPl_tTw

Categories: HCS, HCA & Biology
Tags:

0 Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Posts

Biomimesys

BIOMIMESYS hydroscaffold for your coronavirus-related research in 3D

Clinicians and researchers worldwide are actively studying the mechanisms governing the infection of humans by SARS-CoV-2 and its consequences on their health, with the objective is to find effective therapies. We all aknowledge their important Read more…

Biomimesys

Impact of neurodegenerative diseases on extracellular space organization and diffusion through hyaluronan remodeling

Soria et al. has published this year an interesting study about the modification leading by synucleopathy on the nanoscale organization and diffusivity of the extracellular space, through hyaluronan remodeling. Indeed the extracellular space (ECS), composed Read more…

Biomimesys

3D co-culture of dopaminergic neurons and astrocytes in BIOMIMESYS® Brain to study Parkinson’s disease

Parkinson’s disease affects more than 6 million people worldwide. This neurodegenerative disease is characterized by the death of dopaminergic neurons in the substantia nigra pars compacta, with intracellular accumulation of alpha-synuclein aggregates known as Lewi Read more…